• Home
  • Medlab Clinical LTD

Medlab Clinical LTD

About Medlab Clinical LTD

Medlab Clinical LTD
(ASX.MDC)

Medlab Clinical is a research and development facility centering development in new therapeutics for chronic diseases.

Chronic diseases present a significant global unmet need, to which Medlab's core activities focuses on:

1/. late stage trials for non-opioid analgesics, 
2/. sub micron delivery platforms for small mole...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Australia
  • On CPHI since:
    2020
Contact info
Show contact info Hide contact info

Products from Medlab Clinical LTD (3)

  • NanoCBD

    Product NanoCBD

    NanoCBD is a formulation containing 16.67 mg/mL cannabidiol (CBD) as active ingredient, in a sub-micron spray applied to the oro-buccal membrane. The CBD is sourced from cannabis (hemp) strains and extracted from plant parts that produce high levels of CBD, but no THC.

    IP RIGHTS:
    Paten...
  • MultiBiotic™

    Product MultiBiotic™

    MultiBiotic™ is an evidence-based multi-species probiotic specifically designed to target end-organ function and support gastrointestinal health and maintenance. MultiBiotic™ is an ARTG listed medicine and available in Pharmacies and HCP's in AU, NZ, SG and HK. Presently MultiBiotic™ is in Phase ...
  • NanaBidial™

    Product NanaBidial™

    NanaBidial™ is an investigative new product containing 20 mg/mL of Cannabidiol (CBD) and and <1mg/mL of delta-9-tetrahydrocannabinol (THC), in a sub-micron spray applied to the oro-buccal membrane.
    CLINICAL TRIAL:
    The buccal administration of a NanoCelle™ CBD preparation to healthy volunteers:...

Medlab Clinical LTD Resources (1)